Table IV Index
Table of Contents
| Table IV - 3
Cervical Cancer, Invasive and In Situ Indiana 1996 |
||||||
Top 10 Histologies |
||||||
| Histology | ICD-O-2 Code | Number | Percent | |||
| Squamous cell carcinoma | 807 | 645 | 70.3 | |||
| Carcinoma | 801 | 645 | 18.2 | |||
| Adenocarcinoma, Code 814 | 814 | 66 | 7.2 | |||
| Adenosquamous carcinoma | 856 | 20 | 2.2 | |||
| Adenocarcinoma, Code 826 | 826 | 4 | 0.4 | |||
| Mucinous adenocarcinoma | 848 | 4 | 0.4 | |||
| Papillary carcinoma | 805 | 3 | 0.3 | |||
| Clear cell carcinoma | 831 | 2 | 0.2 | |||
| TBD | 889 | 2 | 0.2 | |||
| Small cell carcinoma | 804 | 1 | 0.1 | |||
| 100% microscopically confirmed | ||||||
| Age and Sex | ||||||
| Age at Diagnosis |
Total Number |
Percent |
Male Number |
Percent |
Female Number |
Percent |
| 0-9 | 0 | 0.0 | -- | -- | 0 | 0.0 |
| 10-19 | 26 | 2.8 | -- | -- | 26 | 2.8 |
| 20-29 | 215 | 23.4 | -- | -- | 215 | 23.4 |
| 30-39 | 294 | 32.0 | -- | -- | 294 | 32.0 |
| 40-49 | 185 | 20.2 | -- | -- | 185 | 20.2 |
| 50-59 | 74 | 8.1 | -- | -- | 74 | 8.1 |
| 60-69 | 56 | 6.1 | -- | -- | 56 | 6.1 |
| 70-79 | 45 | 4.9 | -- | -- | 45 | 4.9 |
| 80-89 | 21 | 2.3 | -- | -- | 21 | 2.3 |
| 90+ | 2 | 0.2 | -- | -- | 2 | 0.2 |
| Unspecified | 0 | 0.0 | -- | -- | 0 | 0.0 |
| TOTAL | 918 | 100.0 | -- | -- | 918 | 100.0 |
| Race | ||||||
| Total | White | Black | Other | |||
| Number | 918 | 817 | 79 | 22 | ||
| Percent | 100.0% | 89.0% | 8.6% | 2.4% | ||
| Stage at Diagnosis | ||||||
| Total | In Situ | Local | Regional | Distant | Unknown | |
| Number | 918 | 621 | 177 | 86 | 21 | 13 |
| Percent | 100.0% | 67.6% | 19.3% | 9.4% | 2.3% | 1.4% |
| Age-Specific Incidence Rates by Sex and Race | ||||||
| Age at Diagnosis |
White Male |
White Female |
Non-White Male |
Non-White Female |
Total | |
| 0-4 | -- | 0.0 | -- | 0.0 | 0.0 | |
| 4-9 | -- | 0.0 | -- | 0.0 | 0.0 | |
| 10-14 | -- | 0.6 | -- | 0.0 | 0.5 | |
| 15-19 | -- | 0.0 | -- | 0.0 | 0.0 | |
| 20-24 | -- | 1.1 | -- | 0.0 | 1.0 | |
| 25-29 | -- | 8.4 | -- | 4.4 | 8.0 | |
| 30-34 | -- | 11.2 | -- | 8.7 | 11.0 | |
| 35-39 | -- | 19.8 | -- | 12.3 | 19.1 | |
| 40-45 | -- | 18.0 | -- | 22.9 | 18.4 | |
| 45-49 | -- | 17.3 | -- | 5.8 | 16.4 | |
| 50-54 | -- | 11.6 | -- | 23.5 | 12.5 | |
| 55-59 | -- | 16.8 | -- | 0.0 | 15.5 | |
| 60-64 | -- | 7.3 | -- | 41.7 | 10.1 | |
| 65-69 | -- | 17.3 | -- | 34.8 | 18.6 | |
| 70-74 | -- | 16.7 | -- | 61.3 | 19.4 | |
| 75-79 | -- | 15.5 | -- | 0.0 | 14.6 | |
| 80-84 | -- | 16.3 | -- | 122.6 | 21.7 | |
| 85+ | -- | 6.9 | -- | 35.0 | 8.2 | |
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||
